Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by GrahamBon Nov 01, 2023 1:04pm
154 Views
Post# 35711591

History Repeats Itself

History Repeats ItselfIt is certainly exciting to keep looking forward.
yet, when the same old story is replayed again and agan, and the "story" never gets traction, one starts to question if the buisness will ever show its able to make sales and show there is demand.
This becomes critical when the oxygen of a buisness, cash flow, runs dry. Yoiu either earn it, boroow it, or finance it and dilute.
Thus far its been the latter.
Here is a presser from 10 years ago, does history rhyme or repeat?

"By comparison, VMS takes mere minutes and is accessed via an imaging lab and the internet on a fee for service basis. The VMS Diagnostic system consists of commercial off-the-shelf computer and tracking system sensor, along with patented and proprietary methods and software. The VentriPoint Medical System (VMS) provides the cardiologist with critically important information regarding a patient’s RV volume in a manner that is inexpensive, easily accessible, and accurate. The technology uses video output from a basic 2D ultrasound system which could be purchased on the secondary market for as low as $20,000.00. The entire VMS procedure from acquiring the 2D images to a final report with a complete surface reconstruction of the right ventricle with volume and function information and historical data can be completed in less than 15 minutes.

According to Joseph Ashley, CEO of VentriPoint Diagnostics and its wholly owned subsidiary, VentriPoint, Inc (TSX: V.VPTStock Forum), "We are on the cusp of commercially entering a 5 billion dollar a year global market.""


Still on the cusp, or the precipice?
All IMO
Do your own DD
I did, and am delighted to watch on the sidelines and wait.

<< Previous
Bullboard Posts
Next >>